Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Depreciation & Amortization (CF): 2022-2023

Historic Depreciation & Amortization (CF) for Therapeutics (LENZ) over the last 2 years, with Dec 2023 value amounting to $4,000.

  • Therapeutics' Depreciation & Amortization (CF) fell 99.41% to $4,000 in Q4 2023 from the same period last year, while for Dec 2023 it was $15,000, marking a year-over-year decrease of 99.36%. This contributed to the annual value of $58,000 for FY2024, which is 286.67% up from last year.
  • Per Therapeutics' latest filing, its Depreciation & Amortization (CF) stood at $4,000 for Q4 2023, which was down 0.00% from $4,000 recorded in Q3 2023.
  • In the past 5 years, Therapeutics' Depreciation & Amortization (CF) registered a high of $682,000 during Q4 2022, and its lowest value of $3,000 during Q1 2023.
  • Moreover, its 2-year median value for Depreciation & Amortization (CF) was $222,000 (2022), whereas its average is $295,875.
  • Data for Therapeutics' Depreciation & Amortization (CF) shows a maximum YoY slumped of 99.41% (in 2023) over the last 5 years.
  • Therapeutics' Depreciation & Amortization (CF) (Quarterly) stood at $682,000 in 2022, then plummeted by 99.41% to $4,000 in 2023.
  • Its last three reported values are $4,000 in Q4 2023, $4,000 for Q3 2023, and $4,000 during Q2 2023.